We are live on ! Find out more
TSRX

TRIUS THERAPEUTICS INC COM STK (DE)
TSRX

Delisted

TSRX was delisted on the 11th of September, 2013.

84 hedge funds and large institutions have $145M invested in TRIUS THERAPEUTICS INC COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

79% less call options, than puts

Call options by funds: $623K | Put options by funds: $2.97M

Holders
84
Holders Change
+84
Holders Change %
% of All Funds
2.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
84
Increased
Reduced
Closed
Calls
$623K
Puts
$2.97M
Net Calls
-$2.34M
Net Calls Change
-$2.34M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
BRWA
76
B. Riley Wealth Advisors
Florida
$89K +$81.2K +11,000 New
LTFS
77
Ladenburg Thalmann Financial Services
Florida
$87K +$79.6K +10,775 New
Dimensional Fund Advisors
78
Dimensional Fund Advisors
Texas
$61K +$55.2K +7,473 New
SO
79
STRS Ohio
Ohio
$61K +$55.4K +7,500 New
Barclays
80
Barclays
United Kingdom
$21K +$18.8K +2,551 New
BPBT
81
Boston Private Bank & Trust
Massachusetts
$20K +$18.5K +2,500 New
California Public Employees Retirement System
82
California Public Employees Retirement System
California
$9K +$8.12K +1,100 New
BlackRock
83
BlackRock
New York
$9K +$8.34K +1,129 New
Royal Bank of Canada
84
Royal Bank of Canada
Ontario, Canada
$8K +$7.39K +1,000 New

TSRX Hedge Fund Activity: Q2 2013 in Review

84 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) for Q2 2013, worth a combined $145M.

Buyers outnumbered sellers: 84 funds opened new TSRX positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.

  • 84 institutional investors held TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $145M of TRIUS THERAPEUTICS INC COM STK (DE) stock for Q2 2013.
  • 84 funds opened new TRIUS THERAPEUTICS INC COM STK (DE) positions in Q2 2013 and 0 closed out, a net change of +84 holders.

Based on aggregated 13F filings for Q2 2013.